HEALTHâRELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2) VERSUS R PLUS PLACEBO
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 232-234
10.1002/hon.45_2630